Today: 30 June 2026
Shopify stock price today: SHOP ends 2025 lower as New Year break shifts focus to jobs data and earnings
1 January 2026
1 min read

Shopify stock price today: SHOP ends 2025 lower as New Year break shifts focus to jobs data and earnings

NEW YORK, January 1, 2026, 16:03 ET — Market closed

Shopify Inc. (SHOP) shares last closed down 1.7% at $160.97 in the year’s final session on Dec. 31, after trading between $160.55 and $164.21. About 4.2 million shares changed hands.

The late-year dip matters because Shopify is treated as a “long-duration” growth stock — one whose expected profits sit further out — making it more sensitive to shifts in interest-rate expectations.

That sensitivity is back in focus heading into early January, when traders typically recalibrate risk after holiday-thinned trading and start positioning for the first major economic releases of the year.

U.S. stocks ended the final session of 2025 lower, with technology among the laggards as volumes stayed light, Reuters reported. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity is low. Reuters

Moves in e-commerce and internet names were mixed. Amazon.com (AMZN) fell 0.7% in the latest session, while Wix.com (WIX) edged up about 0.3%.

Shopify sells software that helps merchants run online stores, process payments and manage other commerce functions. Investors tend to use it as a read-through on small-business activity and consumer spending on the web.

One key metric is gross merchandise volume, or GMV — the total value of goods sold through merchants on the platform. Traders also watch “take rate,” shorthand for how much Shopify earns per dollar of GMV, across payments, shipping and other merchant services.

The company has been pushing product upgrades tied to automation and AI. In December, Shopify unveiled its Winter ’26 Edition, outlining more than 150 platform updates, and it also published Black Friday-Cyber Monday data showing $14.6 billion in sales through merchants on its platform, up 27% from a year earlier.

The next fundamental checkpoint will be Shopify’s holiday-quarter report, where investors will look for confirmation that that spending momentum carried through December. In November, Shopify forecast holiday-quarter revenue growth in the mid-to-high 20% range, while higher operating expenses — including spending tied to AI features and marketing — weighed on profit.

Before the next session, traders will be watching how risk assets reopen after the New Year’s Day shutdown, with U.S. exchanges set to resume trading on Friday, Jan. 2.

The first big macro catalysts arrive the following week: the U.S. Employment Situation report for December is scheduled for Jan. 9, and the Consumer Price Index for December is due Jan. 13, according to the Bureau of Labor Statistics calendar.

Market calendars tracked by MarketScreener list Shopify’s fourth-quarter 2025 earnings release as projected for Feb. 17. Investors typically focus on GMV growth, subscription revenue, merchant-services growth and operating expense trends when the company reports.

On the chart, $160 is the near-term line investors are watching after Wednesday’s low, while a move back above the mid-$160s would signal that year-end selling pressure is fading.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
Chevron stock today: CVX steadies near $152 as oil logs steepest annual drop since 2020
Previous Story

Chevron stock today: CVX steadies near $152 as oil logs steepest annual drop since 2020

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap
Next Story

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap

Go toTop